Montag & Associates’s Balchem Corp BCPC Stock Holding History

Montag & Associates’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45K	Buy	9 +2	+29%	+$332	﹤0.01%	904
2026 Q1	$1.24K	Sell	7 -4	-36%	-$679	﹤0.01%	884
2025 Q4	$1.74K	Sell	11 -3	-21%	-$458	﹤0.01%	876
2025 Q3	$2.08K	Buy	14 +5	+56%	+$788	﹤0.01%	913
2025 Q2	$1.46K	Hold	9	–	–	﹤0.01%	885
2025 Q1	$1.42K	Buy	9 +3	+50%	+$492	﹤0.01%	925
2024 Q4	$936	Hold	6	–	–	﹤0.01%	957
2024 Q3	$1.01K	Sell	6 -2	-25%	-$341	﹤0.01%	979
2024 Q2	$1.2K	Hold	8	–	–	﹤0.01%	914
2024 Q1	$1.2K	Buy	+8	New	+$1.19K	﹤0.01%	908

Other funds holding BCPC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Montag & Associates's BCPC Position: Q2 2026 in Review

Montag & Associates increased its Balchem Corp (BCPC) stake by 29% in Q2 2026, buying an estimated $332 and bringing the position to 9 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #904.

Montag & Associates first reported a position in BCPC in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.08K in Q3 2025. 417 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.

Montag & Associates held 9 shares of Balchem Corp worth $1.45K as of Q2 2026.
Montag & Associates bought 2 Balchem Corp shares in Q2 2026, an estimated $332.
Balchem Corp made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #904 holding.
Montag & Associates first reported a position in Balchem Corp in Q1 2024 and has held it in 10 quarters since.
Montag & Associates's Balchem Corp position peaked at $2.08K in Q3 2025.
417 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.